title: [Pharmacological and clinical profile of bixalomer (Kiklin(®) capsules): a new therapeutic agent for hyperphosphatemia].
authors.affiliation: keiichi.taniguchi@astellas.com
authors.forename: Keiichi
authors.initials: K
authors.lastname: Taniguchi
authors.forename: Hirotoshi
authors.initials: H
authors.lastname: Kakuta
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Tomura
authors.forename: Seiji
authors.initials: S
authors.lastname: Kaku
authors.forename: Wataru
authors.initials: W
authors.lastname: Uchida
mesh_terms: D000818:Animals; D002214:Capsules; D002614:Chelating Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003327:Coronary Disease / Q000209:etiology; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology; D054559:Hyperphosphatemia / Q000188:drug therapy* / Q000209:etiology; D010756:Phosphoric Acids / Q000378:metabolism; D011073:Polyamines / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis / Q000009:adverse effects; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000378:metabolism; D012306:Risk
chemical_list: D002214:Capsules; D002614:Chelating Agents; D010756:Phosphoric Acids; D011073:Polyamines; C000589735:bixalomer; C030242:phosphoric acid